SCM
KLRS

Suvretta Capital Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Suvretta Capital Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,696
Closed -$1.07M – 126
2020
Q3 		$1.07M Buy
+1,696
New +$1.07M 0.02% 83